2m 2m 2m 2m 2m 2m 2m
SHATTUCK LABS (STTK)
NASDAQ
$4.90+$0.14 (+3.05%)
Price as of Jun 03, 2026 7:02 PM EDT- $456.2MMarket Cap
- 377.45%1-Year Change
- BiotechnologyIndustry
SHATTUCK LABS (STTK)
$4.90+$0.14 (+3.05%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.0M -82.52% | 5.7M +245.26% | 1.7M +154.14% | 652,000 -97.83% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 1.0M -82.52% | 5.7M +245.26% | 1.7M +154.14% | 652,000 -97.83% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -35.3M -47.52% | -67.2M -9.55% | -74.3M -10.36% | -82.9M +46.56% | |
Depreciation and Amortization Expense | 3.7M -3.68% | 3.8M -5.27% | 4.0M +31.53% | 3.1M +122.68% | |
Total Operating Expenses | 52.5M -39.15% | 86.3M -7.83% | 93.6M -9.97% | 104.0M +38.11% | |
Operating Profit | -51.5M -36.07% | -80.6M -12.39% | -92.0M -11.01% | -103.3M +128.26% | |
Interest Income | 2.7M -47.76% | 5.2M +10.82% | 4.7M +193.28% | 1.6M +154.72% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 2.7M -47.76% | 5.2M +10.82% | 4.7M +193.28% | 1.6M +154.72% | |
Total Nonoperating Income and Expense | 2.7M -47.66% | 5.2M +10.69% | 4.7M +236.63% | 1.4M +369.15% | |
Income before Taxes | -51.5M -36.07% | -80.6M -12.39% | -92.0M -11.01% | -103.3M +128.26% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | 222,000 N/A | N/A N/A | N/A N/A | |
Net Income | -48.8M -35.28% | -75.4M -13.62% | -87.3M -14.37% | -101.9M +126.68% | |
Net Income from Continuing Operations Applicable to Common | -48.8M -35.28% | -75.4M -13.62% | -87.3M -14.37% | -101.9M +126.68% | |
Basic EPS and Net Income | -0.70 -53.02% | -1.49 -27.32% | -2.05 -14.94% | -2.41 +125.23% | |
Diluted EPS and Net Income | -0.70 -53.02% | -1.49 -27.32% | -2.05 -14.94% | -2.41 +125.23% | |
Basic Weighted Average Shares | 69.6M +37.09% | 50.8M +19.15% | 42.6M +0.52% | 42.4M +0.82% | |
Diluted Weighted Average Shares | 69.6M +37.09% | 50.8M +19.15% | 42.6M +0.52% | 42.4M +0.82% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 54.2M -5.57% | 57.4M -54.32% | 125.6M +165.15% | 47.4M -48.65% | |
Short-Term Investments | N/A N/A | N/A N/A | 5.0M -95.61% | 113.9M -35.48% | |
Cash and Cash Equivalents and Short-Term Investments | 54.2M -5.57% | 57.4M -56.07% | 130.6M -19.01% | 161.3M -40.00% | |
Total Current Assets | 82.5M +4.12% | 79.2M -44.69% | 143.2M -22.41% | 184.6M -35.97% | |
Accumulated Depreciation | 16.7M +26.16% | 13.2M +39.04% | 9.5M +66.51% | 5.7M +105.36% | |
Property and Plant and Equipment and Net | 6.1M -37.69% | 9.8M -28.92% | 13.8M -21.88% | 17.7M +77.81% | |
Total Long-Term Assets | 1.4M -28.93% | 2.0M -20.39% | 2.5M -17.24% | 3.1M +705.51% | |
Total Assets | 91.0M -0.03% | 91.0M -42.94% | 159.6M -22.29% | 205.3M -31.23% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 7.1M -20.92% | 8.9M -22.14% | 11.5M -54.12% | 25.0M +1.54% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 1.6M -36.79% | 2.5M -26.42% | 3.4M -18.94% | 4.2M +89.88% | |
Total Liabilities | 8.6M -24.40% | 11.4M -23.12% | 14.9M -49.06% | 29.2M +8.84% | |
Retained Earnings | -430.5M +12.79% | -381.7M +24.62% | -306.3M +39.86% | -219.0M +87.08% | |
Total Stockholders Equity | 82.4M +3.47% | 79.6M -44.97% | 144.7M -17.85% | 176.2M -35.19% | |
Total Shares Outstanding | 63.3M +32.62% | 47.7M +0.96% | 47.3M +11.49% | 42.4M +0.12% | |
Cash Flow | |||||
Cash from Operating Activities | -39.9M -34.10% | -60.5M -25.50% | -81.2M -14.04% | -94.5M +65.45% | |
Capital Expenditures | 71,000 +20.34% | 59,000 -85.50% | 407,000 -96.50% | 11.6M +46.53% | |
Cash from Investing Activities | -7.9M -7.33% | -8.5M -107.68% | 110.9M +124.24% | 49.4M +573.41% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 44.6M +5,563.79% | 787,000 -98.38% | 48.6M +28,330.41% | 171,000 -91.14% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -5,150.80% +265.75% | -1,408.27% -74.62% | -5,549.61% -64.98% | -15,848.01% +10,408.51% | |
Return on Assets | -53.61% -10.91% | -60.18% +25.77% | -47.85% +18.26% | -40.46% +191.30% | |
Return on Equity | -60.25% -10.38% | -67.23% +23.55% | -54.41% +19.55% | -45.52% +194.33% | |
Revenue Growth | -82.52% -133.65% | 245.26% +59.12% | 154.14% +257.56% | -97.83% -148.39% | |
Current Ratio | 11.70 +31.65% | 8.88 -28.96% | 12.51 +69.13% | 7.39 -36.94% | |
Cash Ratio | 7.68 +19.41% | 6.44 -41.33% | 10.97 +477.97% | 1.90 -49.43% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow